Skip to content

Insider · CIK 0001578408

Nick Leschly

director

Files at BLUE (bluebird bio, Inc.), TSVT (2seventy bio, Inc.). First filing Jan 7, 2025, latest Jan 7, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $255k sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
43Moderate
TSVTsell 4
2seventy bio, Inc.
$255k
86,870 shares
-7%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 30, 2025BLUE
bluebird bio, Inc.
UTender of shares
Common Stock
-14,416--1,245Jun 3, 2025
May 30, 2025BLUE
bluebird bio, Inc.
UTender of shares
Common Stockindirect: Nick Leschly 2001 Trust
-2,284--0Jun 3, 2025
May 30, 2025BLUE
bluebird bio, Inc.
UTender of shares
Common Stockindirect: Nick Leschly Irrevocable GST Trust of 2019
-6,150--0Jun 3, 2025
Jun 2, 2025BLUE
bluebird bio, Inc.
DDisposition to issuer
Common Stock
-1,245--0Jun 3, 2025
May 13, 2025TSVT
2seventy bio, Inc.
DDisposition to issuer
Common Stock
-335,964--897,642May 15, 2025
May 13, 2025TSVT
2seventy bio, Inc.
UTender of shares
Common Stock
-897,642--0May 15, 2025
May 13, 2025TSVT
2seventy bio, Inc.
UTender of shares
Common Stockindirect: Nick Leschly 2001 Trust
-15,233--0May 15, 2025
May 13, 2025TSVT
2seventy bio, Inc.
UTender of shares
Common Stockindirect: Nick Leschly Irrevocable GST Trust of 2019
-41,000--0May 15, 2025
May 13, 2025TSVT
2seventy bio, Inc.
DDisposition to issuer
Stock Options (Right to buy)derivative
-469,000--0May 15, 2025
Jan 3, 2025TSVT
2seventy bio, Inc.
SOpen-market sale
Common Stock
-85,978$2.94$252k1,234,498Jan 7, 2025
Jan 6, 2025TSVT
2seventy bio, Inc.
SOpen-market sale
Common Stock
-892$2.78$2,4781,233,606Jan 7, 2025
Nov 6, 2024BLUE
bluebird bio, Inc.
AGrant or award
Common Stock
+24,900$0.00$0315,839Nov 8, 2024
Nov 6, 2024BLUE
bluebird bio, Inc.
AGrant or award
Stock Option (right to buy)derivative
+49,850$0.00$049,850Nov 8, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Nick Leschly: insider trades and track record | InsiderTell